BRCA2 and breast cancer: However, for women >40 years old, with FFTP between 24 and 29 years old, increased BC risk was observed in BRCA2 mutation carriers compared with BRCA2 mutation carriers whose age at FFTP was ≤23 years old (HR=3.24, 95% CI=1.43–7.40).